Novo Nordisk's parent company, Novo Holdings, has acquired Catalent, which is set to enhance production capacity for NVO’s ...

High profile failures and long timeframes for revenue have shifted investment away from Phase I, as VCs seek to mitigate risk ...

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

The all-cash deal has involved Novo Holdings acquiring Catalent for $16.5bn, including debt. It will then sell three of ...

Henrik Wulff, the man in charge of product supply at Novo Nordisk, just spent $11 billion to try to fill an ocean. Novo has ...

Novo Holdings has completed the previously announced acquisition of Catalent in a $16.5bn all-cash transaction. The European ...

Get the latest fund ideas, market commentary, views and opinions from Fidelity’s savings and investment experts on investment ...

Novo Holdings (NVO) has acquired Catalent (CTLT) in a deal that closed on December 18.Pick the best stocks and maximize your portfolio:Discover ...

Pain has really been out of favor in the industry up until very recently,” said John Mulcahy, SiteOne Therapeutics’ CEO. The ...

Novo Holdings completes $16.5 billion acquisition of Catalent Inc, with Novo Nordisk A/S acquiring Catalent's fill-finish sites in Italy, USA, and Belgium.